*Inclusion criteria:*
Item
*Inclusion criteria:*
boolean
C1512693 (UMLS CUI [1,1])
Cases: Fasting serum triglycerides (TGs) > 2.3 mmol/L (200 mg/dL)
Item
Cases: Fasting serum triglycerides (TGs) > 2.3 mmol/L (200 mg/dL)
boolean
C1512693 (UMLS CUI [1,1])
C1706256 (UMLS CUI [1,2])
C0582824 (UMLS CUI [1,3])
Controls: Fasting serum TGs < 1.7 mmol/L (150 mg/dL)
Item
Controls: Fasting serum TGs < 1.7 mmol/L (150 mg/dL)
boolean
C1512693 (UMLS CUI [1,1])
C0009932 (UMLS CUI [1,2])
C0582824 (UMLS CUI [1,3])
*Exclusion criteria:*
Item
*Exclusion criteria:*
boolean
C0680251 (UMLS CUI [1,1])
Cases: Type 2 diabetes, morbid obesity (BMI > 40 kg/m<sup>2</sup>), and fasting serum TGs > 6.8 mmol/L (600 mg/dL)
Item
Cases: Type 2 diabetes, morbid obesity (BMI > 40 kg/m<sup>2</sup>), and fasting serum TGs > 6.8 mmol/L (600 mg/dL)
boolean
C0680251 (UMLS CUI [1,1])
C1706256 (UMLS CUI [1,2])
C4014362 (UMLS CUI [1,3])
C0028756 (UMLS CUI [1,4])
C1305855 (UMLS CUI [1,5])
C0582824 (UMLS CUI [1,6])
Controls: The use of lipid lowering drugs, type 2 diabetes, and morbid obesity (BMI > 40 kg/m<sup>2</sup>)
Item
Controls: The use of lipid lowering drugs, type 2 diabetes, and morbid obesity (BMI > 40 kg/m<sup>2</sup>)
boolean
C0680251 (UMLS CUI [1,1])
C0009932 (UMLS CUI [1,2])
C0086440 (UMLS CUI [1,3])
C4014362 (UMLS CUI [1,4])
C0028756 (UMLS CUI [1,5])
C1305855 (UMLS CUI [1,6])